HYPERBARIC RE-RESPIRATION AS AN OPTIMIZATION METHOD OF COMPLEX THERAPY OF ABACTERIAL CHRONIC PROSTATITIS IN MILITARY PERSONNEL

The research objective is an assessment of hyperbaric re-respiration (HRR) effectiveness in treatment of military personnel suffering from chronic abacterial prostatitis (CAP). The research type is prospective (cohort), clinical and physiological. The subjects are 38 patients with CAP in the acute phase (category III A and III B), aged 32-46, were randomly allocated into 3 groups depending on the kind of therapy: the control group - conventional treatment of CAP in the acute phase (n = 10); the experimental group (n = 14) - traditional therapy and 12-14 hyperbaric oxygen therapy treatments (35-40-minute stay in the oxygen chamber under pressure about 153 kPa); the treatment group (n = 14) - the traditional therapy and a course of HRR (12-14 treatments, 35-40 minute stay under the conditions of higher oxygen (27.9 kPa) and carbon dioxide (3.4 kPa) partial pressure produced in the pressure chamber at a total pressure of about 153 kPa). A comparative assessment of treatment effectiveness performed by using a standardized total score of symptoms of chronic prostatitis (CP), including the pain, dysuria, prostatorrhea, quality of life (QOL) scale as a basis for calculation of the clinical index of CP (CI-CP). Initial examination revealed the presence of acute CAP in all patients, manifested itself in the increased value of CI-CP in the range of 22-35 points, and corresponded with the severity of symptoms of the disease as moderate or frank degree on the standardized scale. The treatment was followed by the highly statistically significant (p <0.001) decrease in CI-CP, QOL increase in all patients (up to 5-16 points), but in the treatment group compared to the other groups, the best results were observed in the dynamics of these parameters (p = 0.030 -0.029). An increase of significance intergroup differences in CI-CP and QOL index was recorded after 6 months. Therefore, prescription of HRR contributes to enhancing of effectiveness of treatment of CAP patients, accelerating recovery of disturbed functions, extension of relapse-free period, improving of the patients' quality of life.